Evaluating and accelerating treatment development:
Identifying, developing, assessing, and scaling up drug products
- Playing a catalytic role in evaluating new and repurposed drugs for patients with COVID-19
- Performing antiviral screening assays for repurposing pre-approved drugs for COVID-19